造血干细胞-话题@MedSci

#造血干细胞#

227篇内容 | 2879人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271355, encodeId=50d412e1355eb, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Nature：四因子成功诱导人类脐静脉内皮细胞转分化为造血干细胞, objectType=article, longId=37447, objectId=65eb3e447eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65eb3e447eb, replyNumber=0, likeNumber=34, createdTime=2014-07-06, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65eb3e447eb, moduleTitle=Nature：四因子成功诱导人类脐静脉内皮细胞转分化为造血干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65eb3e447eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271354, encodeId=b45712e1354a9, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=ADA 2014：非清髓性自体造血干细胞移植(AHSCT)治疗新发1型糖尿病(T1DM) 中国研究撑起半壁江山, objectType=article, longId=36772, objectId=6b5e36e72d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5e36e72d8, replyNumber=0, likeNumber=32, createdTime=2014-06-21, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5e36e72d8, moduleTitle=ADA 2014：非清髓性自体造血干细胞移植(AHSCT)治疗新发1型糖尿病(T1DM) 中国研究撑起半壁江山, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b5e36e72d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271353, encodeId=7dee12e135371, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Nature：成功实现造血干细胞靶向基因组编辑, objectType=article, longId=36206, objectId=2b85362063c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b85362063c, replyNumber=0, likeNumber=42, createdTime=2014-06-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b85362063c, moduleTitle=Nature：成功实现造血干细胞靶向基因组编辑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b85362063c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271352, encodeId=72b112e1352b3, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=T细胞输注治疗造血干细胞移植后病毒感染, objectType=article, longId=32825, objectId=e39c32825f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39c32825f3, replyNumber=0, likeNumber=37, createdTime=2014-04-05, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39c32825f3, moduleTitle=T细胞输注治疗造血干细胞移植后病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e39c32825f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271351, encodeId=a6a412e1351e5, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Cell Stem Cell：免疫细胞或可调节造血干细胞为白血病治疗提供希望, objectType=article, longId=31557, objectId=549d3155ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=549d3155ea7, replyNumber=0, likeNumber=31, createdTime=2014-03-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=549d3155ea7, moduleTitle=Cell Stem Cell：免疫细胞或可调节造血干细胞为白血病治疗提供希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=549d3155ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271350, encodeId=333112e135002, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Nature：造血干细胞的雌雄差别, objectType=article, longId=30037, objectId=8bd93003e85, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bd93003e85, replyNumber=0, likeNumber=32, createdTime=2014-01-28, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bd93003e85, moduleTitle=Nature：造血干细胞的雌雄差别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bd93003e85)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271349, encodeId=e6cf12e134944, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Lancet Oncol：伏力诺他可预防异基因造血干细胞移植后移植物抗宿主病, objectType=article, longId=28365, objectId=bccb2836528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bccb2836528, replyNumber=0, likeNumber=28, createdTime=2013-12-22, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bccb2836528, moduleTitle=Lancet Oncol：伏力诺他可预防异基因造血干细胞移植后移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bccb2836528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271348, encodeId=ca7812e13480c, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=JCO:AML患者达到第一次完全缓解后推荐进行异基因造血干细胞移植, objectType=article, longId=26673, objectId=0913266e338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0913266e338, replyNumber=0, likeNumber=37, createdTime=2013-11-20, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0913266e338, moduleTitle=JCO:AML患者达到第一次完全缓解后推荐进行异基因造血干细胞移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0913266e338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271347, encodeId=1c4212e1347a1, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=上海医务人员为白血病患者捐献造血干细胞, objectType=article, longId=26609, objectId=1dab2660938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dab2660938, replyNumber=0, likeNumber=44, createdTime=2013-11-16, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dab2660938, moduleTitle=上海医务人员为白血病患者捐献造血干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dab2660938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271346, encodeId=a99f12e13461e, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=中华血液学杂志：急性白血病异基因造血干细胞移植后复发的机制及防治策略, objectType=article, longId=24039, objectId=e51d2403915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e51d2403915, replyNumber=0, likeNumber=50, createdTime=2013-09-08, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e51d2403915, moduleTitle=中华血液学杂志：急性白血病异基因造血干细胞移植后复发的机制及防治策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e51d2403915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271345, encodeId=dd6f12e13456a, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：中国地贫造血干细胞移植治愈率可高达九成, objectType=article, longId=12458, objectId=422d1245832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=422d1245832, replyNumber=0, likeNumber=41, createdTime=2012-12-06, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=422d1245832, moduleTitle=Blood：中国地贫造血干细胞移植治愈率可高达九成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=422d1245832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271344, encodeId=3bf012e13440c, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Diabetes Care：自体造血干细胞移植为1型糖尿病带来希望, objectType=article, longId=7694, objectId=64cae694cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64cae694cc, replyNumber=0, likeNumber=47, createdTime=2012-07-08, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64cae694cc, moduleTitle=Diabetes Care：自体造血干细胞移植为1型糖尿病带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64cae694cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271343, encodeId=fac812e1343fb, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=[ESC 2012]CD34+造血干细胞可安全用于缺血性卒中患者, objectType=article, longId=7032, objectId=847de032c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=847de032c8, replyNumber=0, likeNumber=41, createdTime=2012-06-15, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=847de032c8, moduleTitle=[ESC 2012]CD34+造血干细胞可安全用于缺血性卒中患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=847de032c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271342, encodeId=1c7112e134259, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Nature：鉴定出产生培育造血干细胞微环境的细胞, objectType=article, longId=3865, objectId=c1533865b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1533865b5, replyNumber=0, likeNumber=46, createdTime=2012-02-06, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1533865b5, moduleTitle=Nature：鉴定出产生培育造血干细胞微环境的细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1533865b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血干细胞

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

Nature：四因子成功诱导人类脐静脉内皮细胞转分化为造血干细胞

2014-07-06

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

ADA 2014：非清髓性自体造血干细胞移植(AHSCT)治疗新发1型糖尿病(T1DM) 中国研究撑起半壁江山

2014-06-21

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

Nature：成功实现造血干细胞靶向基因组编辑

2014-06-11

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

T细胞输注治疗造血干细胞移植后病毒感染

2014-04-05

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

Cell Stem Cell：免疫细胞或可调节造血干细胞为白血病治疗提供希望

2014-03-08

zhaojie88 (审核中...)

前往app查看评论内容

#造血干细胞#

Nature：造血干细胞的雌雄差别

2014-01-28

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Lancet Oncol：伏力诺他可预防异基因造血干细胞移植后移植物抗宿主病

2013-12-22

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

JCO:AML患者达到第一次完全缓解后推荐进行异基因造血干细胞移植

2013-11-20

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

上海医务人员为白血病患者捐献造血干细胞

2013-11-16

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

中华血液学杂志：急性白血病异基因造血干细胞移植后复发的机制及防治策略

2013-09-08

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：中国地贫造血干细胞移植治愈率可高达九成

2012-12-06

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Diabetes Care：自体造血干细胞移植为1型糖尿病带来希望

2012-07-08

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

[ESC 2012]CD34+造血干细胞可安全用于缺血性卒中患者

2012-06-15

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Nature：鉴定出产生培育造血干细胞微环境的细胞

2012-02-06

科室
- - 订阅+
  - 更多科室
工具
服务